Vasculitis & polymyalgia rheumatica

Concordance and agreement between different activity scores in polymyalgia rheumatica

RMD OpenPublished Secondary analysis of the SEMAPHORE randomised trial

Authors' conclusion

The correlation between all the PMR-ASs was excellent, reflecting the low weight of CRP.

Study context

Population
Patients with active PMR in the SEMAPHORE trial of tocilizumab vs placebo in PMR with GC dependence100 analysed
Participants
101 patients
Comparison
Agreement between C reactive protein polymyalgia rheumatica activity score (CRP-PMR-AS), ESR-PMR-AS, clin-PMR-AS and imp-CRP-PMR-AS
Primary endpoint
Correlation of the PMR activity scores
Methodological detailspost hoc analysis, superiority, double-blind, placebo-controlled
  • Post hoc analysis
  • Superiority
  • Double-blind
  • Placebo-controlled

Primary result

As reported in the abstract

Correlation between the PMR-ASs (CRP-PMR-AS ≤10 or >10) · week 4 until week 24

ICC and kappa

>0.85

Secondary outcomes

Concordance of cut-off values, clin-PMR-AS vs CRP-PMR-AS

Cut-off values similar, proportion of the time
86%

Original publication

Concordance and agreement between different activity scores in polymyalgia rheumatica. RMD Open. Published 15 March 2024. doi:10.1136/rmdopen-2023-003741

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.